Heart failure & cardiomyopathies

Mineralocorticoid-receptor Antagonists (MRAs) and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials

Circ Heart FailPublished post hoc individual participant data meta-analysis

Authors' conclusion

There was no statistically significant evidence of heterogeneity in the absolute or relative effects of MRAs on clinical outcomes between Black and non-Black patients with HF, regardless of HF phenotype.

Study context

Population
Patients with heart failure (HF) with reduced ejection fraction or HF with mildly reduced/preserved ejection fraction, by self-reported race (Black or non-Black)patients randomized in the 4 trials, 577 (4.2%) identified as Black · Black 577
Participants
13,846 patients
Comparison
MRAs versus placebo, according to self-reported race
Outcome
Composite of:
  • Cardiovascular death
  • First HF hospitalization
Methodological details4 large placebo-controlled trials
  • 4 large placebo-controlled trials

Pooled result

As reported in the abstract

MRA vs placeboHazard ratio (95% CI)
Black patients; 3.9 fewer events per 100 person-years of treatment
0.87(0.66–1.15)
non-Black patients; 2.7 fewer events per 100 person-years of treatment
0.77(0.72–0.82)

Further pooled results

OutcomeHazard ratio (95% CI)
First HF hospitalizationMRAvs placeboBlack patients0.86 (0.63–1.17)
First HF hospitalizationMRAvs placebonon-Black patients0.73 (0.68–0.80)
Cardiovascular deathMRAvs placeboBlack patients0.75 (0.48–1.17)
Cardiovascular deathMRAvs placebonon-Black patients0.81 (0.74–0.90)
  • First HF hospitalization: P interaction =0.36
  • Cardiovascular death: P interaction =0.80

Patient characteristics and event rates, Black vs non-Black

Age, Black versus non-Black (years)
64 versus 70
Rates of HF hospitalizations and death higher in Black than non-Black patients

Effects by HF phenotype

Effects of MRAs in HF with reduced ejection fraction and HF with preserved ejection fraction, individually, were not modified by race

Original publication

MRAs and Race in Heart Failure: An Individual Participant Data Meta-Analysis of Randomized Trials. Circ Heart Fail. Published 7 August 2026. doi:10.1161/circheartfailure.125.014355

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.